Lv6
3096 积分 2023-06-19 加入
Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress
8天前
已完结
Targeting the FAPα/Integrin αvβ1 complex attenuates hepatic stellate cell activation and liver fibrosis
2个月前
已完结
Assessing the clinical progress of the bispecific nanobody sonelokimab
2个月前
已完结
Positive phase II trial of IL-17A–IL-17F-targeting nanobody sonelokimab for PsA
2个月前
已完结
IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study
2个月前
已完结
P0848 Engineering and Development of a Novel Bispecific Antibody Targeting both TL1A and α4β7 for the Treatment of IBD
4个月前
已完结
Target identification and assessment in the era of AI
4个月前
已完结
Trends in target novelty in oncology R&D
4个月前
已完结
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors
4个月前
已完结
High-affinity recombinant antibodies enable a sensitive MRGPRX2-specific ELISA for detecting allergic rhinitis and chronic spontaneous urticaria
4个月前
已完结